Rigel Pharmaceuticals, Inc.

NasdaqGS:RIGL Stock Report

Market Cap: US$301.0m

Rigel Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:RIGL Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Feb 24SellUS$60,082Raul RodriguezIndividual5,289.4US$11.40
05 Feb 24SellUS$14,338Dean SchornoIndividual1,262.8US$11.40
05 Feb 24SellUS$16,496David SantosIndividual1,451.9US$11.40

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of RIGL?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders201,8041.15%
Hedge Funds2,470,78814%
General Public5,215,05629.6%
Institutions9,727,39255.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 64.68% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
8.86%
BlackRock, Inc.
1,561,443US$26.7m3.21%no data
8.72%
Armistice Capital LLC
1,536,000US$26.3m-5.42%0.69%
8.29%
Morgan Stanley, Investment Banking and Brokerage Investments
1,460,675US$25.0m2.66%no data
5.94%
Invesco Capital Management LLC
1,046,206US$17.9m7,890%0.01%
5.59%
The Vanguard Group, Inc.
985,291US$16.8m2.46%no data
5.31%
Soleus Capital Management, L.P.
934,788US$16.0m-10.4%1.27%
2.51%
Assenagon Asset Management S.A.
441,765US$7.5m0%0.01%
2.39%
Acadian Asset Management LLC
421,780US$7.2m-23.3%0.02%
2.27%
Geode Capital Management, LLC
399,663US$6.8m2.27%no data
2.09%
State Street Global Advisors, Inc.
367,795US$6.3m0.7%no data
1.75%
Stonepine Capital Management LLC
309,100US$5.3m1.34%1.93%
1.65%
CM Management, LLC
290,000US$5.0m0%4.19%
1.37%
Voya Investment Management LLC
240,968US$4.1m103%no data
1.01%
Jacobs Levy Equity Management Inc
177,340US$3.0m-25.6%0.01%
0.91%
Macquarie Investment Management Business Trust
160,000US$2.7m0%no data
0.82%
Northern Trust Global Investments
144,251US$2.5m2.99%no data
0.81%
Renaissance Technologies LLC
141,946US$2.4m-2.07%no data
0.74%
Raul Rodriguez
131,163US$2.2m0%no data
0.66%
UBS O'Connor LLC
116,915US$2.0m26.5%0.19%
0.65%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
115,163US$2.0m0%no data
0.56%
Connor, Clark & Lunn Investment Management Ltd.
98,006US$1.7m29.7%0.01%
0.54%
Kennedy Capital Management LLC
94,549US$1.6m5.13%0.04%
0.44%
Charles Schwab Investment Management, Inc.
77,407US$1.3m0%no data
0.42%
Los Angeles Capital Management LLC
74,502US$1.3m34.5%no data
0.38%
SEI Investments Management Corporation
67,099US$1.1m8.68%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 03:03
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Rigel Pharmaceuticals, Inc. is covered by 27 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James BirchenoughBarclays
Clarence PowellBMO Capital Markets Equity Research
James BirchenoughBMO Capital Markets Equity Research